Decreased incidence of febrile neutropenia in Michigan following masking and social distancing orders for the COVID-19 pandemic: A population based cohort study

Figure 1 Incidence of febrile neutropenia in patients with an associated diagnosis of hematologic malignancy compared to those without a diagnosis of hematologic malignancy. Patients with a diagnosis of a hematologic malignancy were significantly more likely to be febrile than those without a diagnosis of hematologic malignancy in Year 0 (21.2% vs 29.3%, P < 0.0001). This difference was not seen after implementation of public health guidelines in Year 1 (20.2% vs 23.8%, P = 0.12).